Accession Number:

ADA277614

Title:

Custom Tailoring Therapy for Breast Cancer Using ERBB-2

Descriptive Note:

Annual rept. 15 Dec 1992-31 Dec 1993

Corporate Author:

GEORGETOWN UNIV WASHINGTON DC

Personal Author(s):

Report Date:

1994-01-14

Pagination or Media Count:

6.0

Abstract:

In order to examine whether erbB-2 protein over-expression influence the survival and tamixifen response in ER positive node negative breast cancer, 937 patients were examined from NSABP trial B-14. No such effect was found. ERBB-2, Breast cancer, Tamoxifen, Estrogen receptor, Survival, Therapy.

Subject Categories:

  • Biochemistry
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE